Research Expert: Sarah Overall
  • Published: Mar 2025
  • Pages: 150
  • SKU: IRTNTR77186

  • Latest News- Hormone Replacement Therapy Market: Hospital pharmacies is expected to lead the Distribution Channel segment during 2024-2028

    The Hormone Replacement Therapy Market is being driven by Development of innovative hormone replacement therapy products

    The Hormone Replacement Therapy Market is expected to grow at a CAGR of 6.67% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 8.44 billion. In the realm of healthcare, Hormone Replacement Therapy (HRT) has emerged as a viable solution for managing symptoms associated with hormonal imbalances in aging populations. Andropause, a condition characterized by a decline in testosterone levels in men, can lead to symptoms such as fatigue, reduced libido, and mood changes. HRT, specifically Testosterone Replacement Therapy (TRT), is utilized to alleviate these symptoms. Furthermore, HRT, particularly estrogen-based therapy, has been extensively researched for its potential cognitive benefits in postmenopausal women, including a protective effect against cognitive decline and Alzheimer's disease. Additionally, HRT is prescribed to manage genitourinary symptoms in women during menopause, such as atrophy and pain during intercourse. Sexual dysfunction, including low libido and erectile dysfunction, is also addressed through HRT in both genders. 

    Get more information on Hormone Replacement Therapy Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on

    • Distribution Channel
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Type
      • Estrogen and progesterone replacement therapy
      • Thyroid hormone replacement therapy
      • HGH replacement therapy
      • Others
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • UK
      • Asia
        • China
        • Japan
      • Rest of World (ROW)

      According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

      • Development of innovative hormone replacement therapy products
      • Increasing prevalence of hormonal disorders
      • Growing global healthcare expenditure

      However, the market also witnesses some limitations, which are as follows:

      • Concerns associated with side effects of hormone replacement therapy
      • High cost of hormone replacement therapy
      • Rise in adoption of non-hormonal therapies

      Benefits of Buying Global Hormone Replacement Therapy Market Research Report by Technavio

      Rich Experience: 20+ years leading global market research, trusted insights across industries.

      Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

      Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

      Market Scope in Hormone Replacement Therapy Market Research Report

      Market Scope

      Report Coverage

      Details

      Page number

      161

      Base year

      2023

      Historic period

      2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 6.67%

      Market growth 2024-2028

      USD 8.44 billion

      Market structure

      market_structure.ucfirst

      YoY growth 2023-2024(%)

      6.22

      Key countries

      US, Germany, UK, China, and Japan

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      Find out which segment is leading the market by accessing the free PDF report

      Research Analysis Overview

      Hormone replacement therapy (HRT) involves the use of synthetic hormones to treat various hormone deficiencies, including those related to thyroid disease, menopause, and growth hormone disorders in women and men. Medical records show that HRT can reduce mortality rates, particularly in women with estrogen therapy for menopause-related illnesses such as hot flashes and osteoporosis risks. General practitioners prescribe oral, parenteral, and transdermal therapies for conditions like hypothyroidism, male hypogonadism, growth hormone deficiency, and hypoparathyroidism. Novel therapies include hGH replacement therapy for growth hormone disorders and parathyroid hormone replacement for hypoparathyroidism. HRT is also used to treat menopause symptoms in women and testosterone replacement therapy for men with hormone deficiencies. HRT can help manage symptoms and improve quality of life for those with hormone imbalances.

      Market Research Overview

      The Hormone Replacement Therapy (HRT) market is a segment of the larger Pharmaceuticals industry within the healthcare sector, as identified by Technavio. This market encompasses businesses involved in the research and development (R&D) or manufacture of hormone replacement therapies, including estrogen therapy for women and potential treatments for thyroid disease and the male population. The global pharmaceuticals market's expansion will primarily be driven by demographic trends, such as the increasing elderly population, with the number of individuals aged 60 and above projected to rise significantly. This demographic shift is expected to fuel the demand for HRT treatments and other pharmaceutical products. Additionally, the market's growth will be influenced by advancements in medical research and technology, which will lead to the development of new therapies and improved treatment methods. Medical records and general practitioners will play a crucial role in the distribution and administration of these therapies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


      Contacts

      Technavio Research
      Jesse Maida
      Media & Marketing Executive
      US: +1 844 364 1100
      UK: +44 203 893 3200
      Email: media@technavio.com
      Website: www.technavio.com/

      Read News Read Less
      Interested in this report?
      Get your sample now!

    Safe and Secure SSL Encrypted

    Technavio

    • 2500 USD

    [5 reports/month/user]

    • 5000 USD

    close
    • Basic Plan [5000 USD/Year]:

      Single User
      Download 5 Reports/Month
      View 100 Reports/Month
      Add upto 3 Users at 625 USD/user

    • Teams Plan [7500 USD/Year]:

      5 User
      Download 5 Reports/Month/User
      View 100 Reports/Month/User
      Add upto 30 Users at 500 USD/user

    *You can upgrade to Teams plan at Subscription page

    close
    • Single:

      One user only.
      Quick & easy download option

    • Enterprise:

      Unlimited user access (Within your organization).
      Complimentary Customization Included

    *For Enterprise license, go to checkout page

    Technavio Get the report (PDF) sent to your email within minutes.